Request for Covid-19 Impact Assessment of this Report
General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students. Online education also supplements the growth of this market. Wolters Kluwer, Mc Graw-Hill, Reed Elsevier, Thomson and Optum Health are some key players in this market. Practice of Medicine and Davidson’s Principles and practice of Medicine are some popular books from Reed Elsevier.
The general medicine education publishing market has been segmented into type and geography. Based on type, the general medicine education market comprises of electronic & online publishing market and Print publishing market. Electronic & online publishing market is further segmented into mobile applications, online reference tools, multimedia content, electronic & digital textbooks & references books, testing & self-assessment, hospital training, and distance learning. Print Publishing Market comprises of custom content publishing, print textbooks & reference books, testing & self-assessment, hospital training and distance learning. Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA.
KEY BENEFITS
KEY MARKET SEGMENTS
MARKET BY TYPE
MARKET BY GEOGRAPHY
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...